Institutional members access full text with Ovid®

Share this article on:

6: EFFECT OF DISEASE SEVERITY ON SURVIVAL IN PATIENTS RECEIVING ANGIOTENSIN II FOR VASODILATORY SHOCK

Szerlip, Harold; Bihorac, Azra; Chang, Steven; Chung, Kevin; Hästbacka, Johanna; Murugan, Raghavan; Favory, Raphael; Tumlin, James; Venkatesh, Balasubramanian; Chawla, Lakhmir; Tidmarsh, George

doi: 10.1097/01.ccm.0000528062.45598.be
Star Research Presentation: Sepsis and Shock

1Baylor University Medical Center, Dallas, TX, 2University of Florida School of Medicine, Gainesville, FL, 3David Geffen School of Medicine at UCLA, Los Angeles, CA, 4Brooke Army Medical Center, Fort Sam Houston, TX, 5University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 6University of Pittsburgh Medical Center, Pittsburgh, PA, 7University Hospital of Lille, Faculty of Medicine, Lille, France, 8University of Tennessee College of Medicine, Chattanooga, TN, 9Princess Alexandra Hospital, Brisbane, QLD, Australia, 10La Jolla Pharmaceutical Company, San Diego, CA

Copyright © by 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.